<< Back to list

Study: PHII-154
Title: A Phase 1/2 Trial of ABT-888, an Inhibitor of Poly(ADP-ribose) Polymerase (PARP), and Topotecan (TPT) in Patients with Solid Tumors (Phase 1) and Relapsed Ovarian Cancer or Primary Peritoneal Cancer (Phase 2) After Prior Platinum Containing First-Line Chemotherapy (NCI # 8329)
PI: Vanessa Kennedy
Phase: II
Condition: Ovarian/Peritoneal Cancer
Coordinator: Stacy Joo (916) 734-4913
Sponsor: CCCP
Age: (Age 18 or above)
Closure/Comment: (temporary closure)
Find out more about this study on the ClincialTrials.gov website here...

View the list of the Clinical Trials Staff

For information about adult cancer clinical trials at UC Davis, please call (916) 734-3604.
For information about pediatric cancer clinical trials at UC Davis, please call (916) 734-2780.
For information about clinical trials at other leading cancer centers, call (800) 4-CANCER.